Introduction
The human enterovirus group comprises 70 pathogenic serotypes within the family Picornaviridae, which are associated with over 20 clinically recognized syndromes (Melnick, 1990) . Asymptomatic infection is by far the most usual outcome of infection with almost all enteroviruses. Regardless of climate, geography, or socio-economic conditions, by the age of 2 years most children have already experienced several enterovirus infections (Melnick, 1990) .
The enteroviruses are small (24-30 nm), non-enveloped, single-stranded RNA viruses, made up of 60 copies of four proteins, VP1 to VP4 (Rueckert, 1990) . The genetic organization and primary structure of enteroviruses have been Author for correspondence: Jeronimo Cello. Present address: Instituto Nacional de Microbiologia, Dr. Carlos (3.
Malbran, Av. Velez Sarsfield 563, (1281 ) Buenos Aires, Argentina. Fax + 54 1 3031801. e-mail virus@malbra.sld.ar extensively studied and these data show that conserved sequences are found in both structural and non-structural proteins (Palmenberg, 1989; Stanway, 1990) .
The humoral immune responses to enteroviral infections have been characterized (Melnick et al., 1950; Tracy et al., 1995) . Serotype-and group-common specific B cell epitopes have been identified on the capsid proteins of enteroviruses (Minor, 1990; Roivainen et al., 1991; Cello et al., 1993) .
In contrast, the nature and specificity of the enterovirus T cell-specific response is less well-characterized. Studies in rodents have shown that each of the four structural virus proteins (VP1 to VP4) contains T cell epitopes and the enterovirus-induced T cell response can be both cross-reactive between different enteroviruses and serotype-specific (Beck & Tracy, 1989; Wang et al., 1989; Katrak et al., 1991; Kutubuddin et al., 1992; Mahon et al., 1992) . The few investigations in humans, the natural host of enteroviruses, seem to confirm some of the findings made in animal models (Beck & Tracy, 1990; Graham et al., 1993; Simons et al., 1993) . However, the fine mapping of the T cell epitopes has only been carried out within VP1 capsid protein.
The immune response to viruses, including the development of an efficient antibody response, is primarily T cell dependent. CD4 + T helper (Th) cells have been divided into at least two different subsets (ThI and Th2), based on the cytokine profiles that they give upon antigen stimulation (Mosmann & Coffman, 1989) . Thl cells secrete interleukin 2 (IL-2), interferon gamma (IFN-7) and tumour necrosis factor beta (TNF-fl) whereas Th2 lymphocytes produce IL-4, IL-5 and IL-10. Although these functionally distinct T cells were originally described in the mouse, human T cell clones have similar, but not identically restricted cytokine profiles (Street & Mosmann, 1991) . The differences in cytokine secretion explain the functional dichotomy between Thl cells, which enhance cellular immunity, and Th2 cells, which regulate the activation of B cells to produce antibody (Paul & Seder, 1994) . The immune response to certain infectious agents in humans and mice, particularly parasites, displays patterns of cytokine production that are predominantly of Thl or Th2 type (Locksley & Scott, 1991; Pearce et al., 1991; Salgame et al., 1991; Romani et al., 1992) . However, it is now clear that in many cases, the human T cell responses do not always fit the Thl/Th2 classification (Graziosi et al., 1994; Romagnani, 1994) .
In this paper, we have used a series of synthetic peptides to define cross-reacting T cell epitopes on the four structural proteins of enteroviruses. Peripheral blood mononuclear cells (PBMC) from healthy human blood donors were stimulated in vitro with six different serotypes of enterovirus and 15 peptides representing conserved regions in the structural proteins of these viruses. Serum neutralizing antibody titres to the viruses were used as an indicator of previous enteroviral exposure. PBMC were tested for their responsiveness to the different viruses and peptides by thymidine incorporation, IFN-7, IL-4 and IL-10 release. Further, we identified the subpopulations of cells necessary for proliferation and cytokine release in response to the different antigens.
Methods
• Subjects. Heparinized peripheral venous blood was obtained from healthy blood donors (BD) at the Blood Center, Ostra Hospital, G6teborg, Sweden. The age of the population studied ranged from 18--65 years. All the donors had been vaccinated against polio. To provide negative controls cord blood was obtained from neonates at the time of parturition as a source of naive cells.
• Viral antigens, Poliovirus 1 (PVl), Coxsackie B3 (CB3), B5 (CB5), B6 (CB6), A9 (CA9) and Echovirus 30 (E30) were obtained from our laboratory collection. Viruses were grown on GMK cells (a continuous cell line of African green monkey kidney origin) and purified as described previously (Samuelson et al., 1990) . After purification, the viruses were heated at 56 °C for I h. Control antigens were prepared from noninfected GMK cells in the same way as described above.
• Synthetic peptides. The peptide sequences from the structural proteins were selected from regions that are conserved among entero- viruses according to the sequence data for different enteroviruses (GenBank release 97). The peptide sequences are given in Table I . Peptides were synthesized on an Applied Biosystems 430A Automated Peptide Synthesizer using t-Boc strategy as described previously (Horal et al., 1991) . Side chain-protected amino acids used were from Nova Biochem and Applied Biosystems. Polymer p-methylbenzhydrylamine resin (Peptides International) was used as the solid phase. Following each amino acid coupling, samples were taken and a quantitative ninhydfin assay was performed, this being considered very important as only a slight reduction in average coupling efficiency dramatically reduces the amount of the desired full-length peptide produced. Only if the coupling efficiency exceeded 99 % for each amino acid was the peptide accepted for further processing. After completion of synthesis, peptides were cleaved from the resin and amino acid side chains were deprotected by acid hydrolysis with anisole and ethanedithiol (Merck) as scavengers. The amino acid sequence of each peptide was confirmed by sequencing with Applied Biosystem's protein sequencer 473A.
• Preparation of PBMC for lymphoproliferative and cytokine assays. Peripheral venous blood was separated by Ficoll-Hypaque gradient centrifugation as directed by the manufacturer (Lymphoprep). After washing, PBMC were seeded into round-bottom 96-well culture plates (Nunc) at 2 x 105 cells per well in a final volume of 0"180 ml Iscove's medium supplemented with antibiotics (100 U/ml pencillin and 100 p.g/ml streptomycin), 10% human AB serum (Sigma), 2 mM-Lglutamine (Gibco) and 10 -5 M-2-mercaptoethanol (Carl Roth). Viral antigens and synthetic peptides (20 p.1/well) were tested at different final concentrations from 0"5-50 ~g/ml. Parallel sets of wells containing PBMC exposed to medium alone, to an unrelated peptide and to noninfected GMK antigen were used as negative controls. As a positive control phytohaemagglutinin (PHA) (Sigma) at 10 pg/ml was included in all experiments. All peptides were screened for cytotoxic activity by the '.09~
trypan blue exclusion test and cell viability was shown to be greater than 90%. The cultures were maintained at 37 °C in a humidified atmosphere supplemented with 5 % CO 2. At the time indicated after initiation of the cultures, aliquots (20 ,l/well) of supernatant were collected and frozen at -20 °C, until being assayed for IL-4, IL-10 and IFN-~ content, respectively. After completion of the different culture periods, 1 ,Ci of [6-dH]-thymidine (Radiochemical Centre; Amersham) was added to each well. Six hours later, cells were harvested in an automated filter cell harvester (Inotech) and incorporation of radioactive thymidine into newly synthesized DNA was measured with an argon-activated-flcounter scintillation counter (Inotech).
The • Estimation of cytokines in culture supernatants. and IFN-7 were determined by a two site ELISA with the use of two monoclonal antibodies to human IL-4, IL-10 and IFN-y respectively, according to the instructions given by the manufacturers (IL-4 and IFNy, Mabtech; and IL-10, Pharmingen). Pooled samples from the culture supematants of three wells were assayed to measure the cytokine content. Three to five pools from the different controls were prepared and assayed. The amounts of cytokine were estimated from standard curves generated for each plate by the inclusion of standardized concentrations of recombinant human IL-4 (Genzyme), IL-10 (R&D Systems), and IFN-7 (Imukin; Boehringer Ingelheim), respectively. The limit of sensitivity of these assays was 15 pg/ml. The supernatant from a given antigenstimulated PBMC was considered positive and the antigen reactive, if the absorbance value obtained was greater than 3 x SD above the mean absorbance value obtained with the respective control supernatant.
• CD4 +, CD8 + and NK depletion of PBMC prior to stimulation.
The beads used for depletion of CD4 + and CD8 + cells were coated with monoclonal antibodies specific for either human CD4 or CD8 (Dynal) whilst those used for NK cell depletion were prepared as described previously (Hellstrand et al., 1994) . Depletion of the different cell subsets was done according to the procedure suggested by the manufacturer. The different cell subsets (2 x 10 s cells/well) were stimulated with the different antigens for proliferation and cytokine production according to the optimal conditions previously established for whole PBMC (see above and Results section). When a double depletion was performed, consecutive rounds of depletion of the different subsets were done using the same procedure as described previously in this section. Flow cytometric analyses were performed after each depletion and demonstrated that depletion efficiency of the CD4 +, CD8 ÷ or NK cells in all cases was ~ 95%. ,As the CD4 molecule is also expressed in monocytes/macrophages which are important antigen-presenting cells (APC), it was also checked whether a reduction of this population of cells might occur when the PBMC were treated with anti-CD4 antibodycoated beads. FACS analyses showed no significant depletion of CD14 + cell population (monocyte/macrophages) after treatment with anti-CD4 antibody-coated beads.
• Study on antigen presentation by MHC class II molecules.
The pool of purified anti-MHC class II monoclonal antibodies (MAbs) was prepared by mixing equal amounts of MAbs to DR, DP and DQ molecules, respectively. Hybridoma cell lines were obtained from the American Type Culture Collection (ATCC HB 104, ATCC HB 145, and ATCC HB I80). The pool of MAbs to MHC class I1 molecules (10 ~g/ml) was added to the medium at the time of initiation of the PBMC cultures.
These PBMC were stimulated with the different antigens for proliferation and cytokine production as described elsewhere in this paper (see above and Results section).
• Neutralization tests. Neutralizing antibody was measured by a microneutralization test as described elsewhere (Melnick et aL, 1979) . The neutralizing titre was defined as the reciprocal dilution of the endpoint at which the majority of the wells showed >7 50% inhibition of cytopathic effect. The 50 % serum neutralization endpoint was calculated by ReedMuench formula. A donor was considered not to have experienced infection with a given enterovirus serotype if the neutralizing antibody titre against that serotype was < I0 (Melnick et al., 1979) .
Results

Optimal conditions for proliferation and cytokine production
Based on the results obtained in the set-up of the working conditions, an optimal concentration of 12"5 ,g/ml and 25 ~g/ml for viral antigens and synthetic peptides respectively, and measurement of proliferation and IFN-7 production at day 6 and 7, were chosen for all subsequent experiments (data not shown). Neither IL-4 nor [L-10 was detected in the samples from antigen-stimulated PBMCs at any time from day 1 to day 7. Low amounts of these cytokines (range 35-500 pg/ml) were detected in supernatants from cells stimulated with PHA (data not presented). IFN-7 levels in the supematants from PHA-stimulated lymphocytes were constantly above 7 ng/ml. Tables 2 and 3 summarize the proliferation and IFN-7 production of PBMC from 10 healthy individuals challenged with the six serotypes of enterovirus. PBMC from all donors except BD8 and BD15 responded to every enterovirus serotype (sI > 2; Table 3 ). The proliferative responses of virusstimulated PBMC were moderate (sI 1-11"2) and showed a broad variation among the donors (A c.p.m, range: 0-I1700 c.p.m., Table 3 ).
Proliferation and IFN-y production of PBMC in response to heat-inactivated enteroviruses
IFN-7 was detected in all supernatants from the different virus-stimulated lymphocytes (Tables 2 and 3 ). Similar to the proliferative response, a great variation in IFN-7 production was seen among individuals (range 150 to ~ 10000 pg/ml). The induction of proliferation and of IFN-y by the different enterovirus antigens were not correlated, in general, among the different donors. For example, BD 11 was a better responder than BD17 with respect to proliferative response whereas the latter produced higher amounts of IFN-7 in response to the different enteroviruses (Table 3) . Similar dissociation was seen between IFN-~ production and proliferation in response to different enterovirus serotypes in individual donors (Table 3) .
The presence of IFN-7 was not detected in the great majority of the supernatants of PBMC challenged with noninfected GMK cells or medium alone, and in all cases the mean Calculation of sl as defined in Methods. Max. response, maximal proliferative response obtained with different viral antigens or synthetic peptides expressed as sL PBMC from each individual exposed to the different viral antigens gave proliferation significantly higher (P < 0-05) than that of the non-infected GMK-stimulated PBMC (range 600-6000 c.p.m.). Proliferative response of PBMC stimulated with the unrelated peptide showed values similar to those exposed to medium alone (range 400-1900 c.p.m.). The proliferative response scored for the reactive peptides were significantly (P < 0"05) above background c.p.m, measured in the respective negative control (PBMC stimulated with the unrelated peptide). # PBMC from 10 blood donors were stimulated for IFN-y with each viral antigen or synthetic peptide. A given viral antigen or synthetic peptide was considered reactive as defined in Methods. Max. response, maximal IFN-y release to culture supematant of PBMC stimulated with the different viraI antigens or synthetic peptides expressed in pg/ml. absorbance values were significantly lower than those in supernatants of virus-stimulated PBMC (data not shown). Finally, PBMC from human cord blood proliferated and produced IFN-y in response to mitogen PHA but no response was recorded when cord blood PBMC were challenged with enteroviral antigens (data not shown).
Titres of human serum neutralizing antibody against enteroviruses and their correlation with cellular immune response
The history of infectious exposure of the donors to the viruses used in the in vitro experiments was determined by testing serum samples for the presence of neutralizing antibody. All individuals had neutralizing antibodies to 3-4 serotypes except BD12 and BD15 who had antibody against 5 serotypes and 1 serotype respectively. However, PBMC from all individual donors produced IFN-7 and/or proliferated even when they were stimulated with the serotype(s) to which the donors lacked neutralizing antibody (Table 3) .
Proliferative response and IFN-T production of peptide-stimulated PBHC
Only 4 out of 15 synthetic peptides induced a significant proliferation of PBMC ( Table 2 ). The reactive peptides represent motifs on VP2 and VP3 structural proteins (Tables I  and 2 ). Except for PBMC from BD9 challenged with peptide E12 (sz 6; 10600 c.p.m.), low responses were detected in peptide-stimulated cells (s[ 1-3"4; proliferation range 500-5000 c.p.m.) ( Table 2 ). The sl values of the stimulatory peptides varied from 2-3"4 but in all cases the proliferative responses scored were significantly (P ~ 0"05) above background c.p.m. measured in the respective negative controls.
Proliferative responses of PBMC stimulated with the unrelated peptide showed values similar to those exposed to medium alone (range 400-1900 c.p.m.). In contrast to the proliferative response, 9 out of the I5 peptides were able to induce IFN-? production (Table 2 ). BD9 and BD14 were the higher responders since they reacted to 5 peptides whereas BD10, I6, and 18 did not respond to any peptide (Table 4) . El0, 12, 13 and 14 peptides, which correspond to sequences on VP2 and VP3 protein, were the most reactive since they induced IFN-? production in 50, 50, 40 and 30% of the donors respectively (Table I and 2 ). In addition, some donors also responded to peptides representing epitopes in the aminoterminal part of VP1 (peptide El, 2, 3,4 and 7; Table I and 2).
Although with lower values than those detected in supernatants from virus-stimulated PBMC, the peptide-specific IFN-7 production also showed wide variation among the individuals (range 30-2300 pg/ml) ( Table 4) . No detectable levels of IFN-? were found in supernatants from PBMC challenged with the unrelated peptide or medium alone.
There was good correlation between the magnitude of the individual donors' response to the viral antigens and the number of reactive peptides (Table 3) , the exceptions being those found in BDS, BD14 and BD16. Specific-IFN-y production to two peptides was detected in supematants of PBMC from BD8 despite the fact that only a low production of IFN-y was induced by enterovirus antigens. Conversely, donor 16 reacted to virus antigens with the release of high quantities of IFN-y but no production of this cytokine was ~-Number of peptides that induce specific proliferation or IFN-7 production of PBMC. :1: Proliferation of PBMC in response to viral antigen is expressed as sl with the background responses to non-infected GMK ceil preparations varying between 600--6000 c.p.m. Proliferation in cultures of PBMC exposed to PHA ranged from 60000-90000 c.p.m. (sI 60-120). Radioactive thymidine incorporation ranged from 500-2100 c.p.m, in cultures containing PBMC exposed to medium alone. § IFN-~, in culture supematant of antigen stimulated-PBMC is expressed in pg/ml. n Neutralizing antibody titre. A titre < 10 indicates no neutralizing antibodies were detected.
detected in supematants of different peptide-stimulated PBMC. In BDI4 where a high proliferative response to different virus serotypes was demonstrated, no reaction with peptide was recorded.
Immunological characterization of virus-and peptidespecific PBMC
To determine the phenotype of the cells responsible for the proliferative response and IFN-y production, PBMC from new donors were depleted of CD4 +, CD8 + and NK cells respectively, and stimulated with the four most reactive peptides (El0, El2, E13 and E14) and with coxsackie B5 (CBS) antigen. Figs 1, 2 and 3 show the best response given by each peptide when tested with PBMC from different donors. Fig. 1 shows that by depletion of CD4 + T cells, the proliferative response to CB5 virus and EI4 peptide was reduced by more than 80% compared to the control whereas no substantial change was observed when depletion of CD8 + and NK cells was performed.
Also, the antigen-specific production of IFN-y by PBMC is mediated by CD4 + T cells since depletion of this subset significantly reduced the release of IFN-? (Fig. 2) . Fig. 2 (b) shows that depletion of NK cells also significantly reduced :1( El0-and CB5-specific IFN-7 production of PBMC from donor H. In addition, as shown in Fig. 2 (c) (donor J), IFN-y production induced by E12 peptide was reduced by 50% compared to non-depleted PBMC when a depletion of the CD8 ÷ or NK subset was performed. In the same individual, depletion of CD8 + T cells reduced CBS-specific IFN-y production by about 50 % compared to the control.
In order to test the relative amounts of IFN-7 produced by each subset and to study whether helper activity from CD4 + T cells is necessary for production of IFN-7 by CD8 + and NK cell subsets, a double depletion of PBMC from donor H and J was done. In doubly depleted CD4+/CD8 +, CD8+/NK and N K / C D 4 + cell populations, the main sources of production of IFN-y were NK, CD4 ÷ and CD8 + cells respectively. Cytokine levels detected in the supernatants of single, double and nondepleted PBMC were then compared and the data are shown in Table 5 . For donor H, El0 peptide-and CB5 virus-specific IFN-y is mainly produced by NK cells but with the need for cooperation of CD4 + T cells. This can be concluded since only in non-depleted and CD8 + T cell-depleted PBMC was the presence of IFN-y recorded whereas the amount of IFN-7 was not detectable or greatly reduced in supematants of the other single-and double-depleted PBMCs.
The analysis of the resuIts obtained from donor J showed that IFN-7 in both E12 and CB5-stimulated PBMC was produced by CD4 + T cells. CD8 + T and NK cells also released IFN-7 provided CD4 + T cells were present.
Since the response was mediated by CD4 + T cells, it would be expected that antigens are presented in association with MHC class II molecules. To test this assumption, monoclonal antibodies to MHC II antigens were added to cultures stimulated with the different antigens. As expected the blockade of MHC II antigens abolished peptide and virusspecific proliferation and IFN-y release by more than 80% (Fig. 3) . , and donor J (c) were depleted of different cell populations prior to in vitro stimulation with E13 peptide, E10 peptide, and E12 peptide at the concentration of 25 ~g/ml respectively. The different subsets were also stimulated with CB5 virus at a concentration of 12.5 I~g/ml. Pooled samples from the culture supernatants of 3 wells were assayed to measure the cytokine content. The IFN-7 production of each depleted cell population is expressed as a percentage of the specific IFN-7 production of nondepleted PBMC (100%). The IFN-7 production (pg/m]) of non-depleted PBMC stimulated with the following antigens was (o) E13 peptide, 125; CB5 virus, 5700; (b) EIO peptide, 140; CB5 virus, 6500; (c) E12 peptide, 950; CB5 virus, 8200.
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Discussion
In this study, we have extended previous investigations defining possible cross-reactive T cell epitopes involved in the human immune response to enterovirus infections. We demonstrated that human PBMC from healthy donors upon challenge with different enterovirus serotypes and synthetic peptides, representing conserved regions in the structural proteins of enteroviruses, responded with proliferation and production of IFN-7, but not IL-4 and IL-10.
The specificity of the T cell response recorded to different enterovirus serotypes is supported by the following observations: (i) significantly higher response of PBMC to enterovirus preparations than to non-infected GMK cell antigen or medium alone; (ii) PBMC from human cord blood used as a source of naive lymphocytes were not capable of responding to enteroviral antigens; and (iii) lymphocyte activation was clue to antigen-driven stimulation and was not the result of a non-specific stimulation induced by components of the viral preparations since the T cell responses were abolished by more than 80 % using blocking antibodies to MHC II antigens.
Regardless of the donors' histories of infection, PBMC from all subjects proliferated and/or produced IFN-7 in vitro against all enteroviruses tested. These results indicate that PBMC from all individuals recognized cross-reactive enterovirus T cell epitopes. This observation was confirmed by the good correlation between the donors' responses to the enterovirus serotypes and to the synthetic peptides representing conserved regions of enteroviruses. However, as has been shown previously (B6ttiger, 1984) , the absence of neutralizing antibodies to a given enterovirus does not exclude the possibility that the individual has experienced infection with that enterovirus.
To be able to interpret and discuss our results in the context of the three-dimensional structures, we used the structure of poliovirus I (Mahoney) as a reference model for enterovirus (Hogle et a]., 1985) .
Our findings indicated the immunodominance of epitopes on VP2 and VP3 in the cross-reactive T cell response to enteroviruses. This is based on the observations that peptides representing epitopes in VP2 (El0 and E12) and VP3 (E13 and EI4) were recognized by 50 % and 40 % of donors respectively. Similar findings were reported when T cell response to Mengo virus, a murine picornavirus, was examined in its natural host (Muir eta[., 1994) . Interestingly, the most reactive peptide in that study and the E12 peptide in our study are located in the same structural region, the loop between the fl-F and fl-I strand. Moreover, the sequence NLRTN, present in both peptides, is very well conserved among enteroviruses, rhinoviruses and cardioviruses (Palmenberg, 1989) . This finding implies that among picomaviruses there is also conservation of important antigenic sites.
The recognition of El0 peptide by 50% of the subjects indicated that an important T cell epitope is located within the fl-A1 and fl-A2 hairpin structure in VP2. Probably, the residues on fl-A2 were the most important for immunorecognition since the E9 peptide, covering fl-A1 and the loop which links both flstrands, was unable to induce T cell activation in any of the donors. Moreover, Mahon et al. (1992) produced a crossreactive murine T cell clone which proliferated in response to the three serotypes of poliovirus and recognized purified VP2. Altogether, these findings showed the T cell immunogenicity of VP2 and also suggest that enterovirus cross-reactive T cell epitopes are situated on this capsid protein.
The significant antigenicity of VP3 protein of picomaviruses in the T cell response has been reported by others and confirmed in this study (Mahon et aI., 1992; Saiz et al., 1992; Hastings et al,, 1993; Muir et al., 1994) . A T cell epitope was mapped in our study in the amino-terminal part of VP3 using the E13 peptide. A study on mice immunized with Sabin vaccine strains also demonstrated recognition of a T cell epitope within the similar region covered by E13 peptide (Mahon eta] ., 1992). However, the investigators of this work showed that the epitope within residues 14-28 on VP3 is serotype specific. A close examination of the amino sequences in the region of EI3 peptide (residues 12-22) revealed variation at positions 16, 18 and 19 among the different sequences of enteroviruses. Strikingly, all the amino acid alterations are found within poIiovirus serotypes whereas the sequence is fully conserved for the rest of the enteroviruses (Palmenberg, 1989) . Thus, we hypothesize that the amino-terminal region of VP3 of polioviruses accommodates serotype-specific T cell epitopes whereas the same region in the other enteroviruses contain cross-reactive T cell epitopes. In addition, mapping of the Mengo virus T cell epitopes showed a prominent T cell epitope in the VP3 amino terminus which corresponds structurally with the epitope represented by E13 peptide.
Another epitope on VP3 represented by E14 peptide was located in the F-G loop. Notably, three of the epitopes identified (El0, 12 and E14) in this study are situated in loop regions. From this observation, it is tempting to speculate that loop regions could have a conformation which is favoured in antigen processing and presentation.
The identified epitopes in VP1 were located in the aminoterminal region of the capsid protein. These epitopes were within or adjacent to the enterovirus cross-reactive B ceil antigenic site which was previously identified by us (Cello et al., 1993) . This finding suggests that the existence of B and T cell epitopes in close proximity is probably required for efficient production of antibodies. Similar linkage of B and T cell epitopes has been observed in other human viruses (DeFreitas et aI., 1985; Graham et at., I993; McCarthy et aI., 1993) .
The inability of peptides representing epitopes in VP4 to induce lymphocyte stimulation was unexpected. In previous work dealing with the characterization of human poliovirusspecific T cell responses, synthetic VP4 was shown to stimulate PBMC proliferation (Simons et al., 1993) . Murine T cell clones which proliferated in response to all three poliovirus serotypes recognized VP4 (Mahon eta] ., 1992). These cross-reactive VP4 clones responded to peptides from the region covered by our non-reactive E16 peptide.
These discrepancies and others found between our results and those obtained by other researchers might be explained in different ways. First, the natural enterovirus host range is narrow (humans and old world primates). Therefore, findings in rodent models might not always reflect the T cell response to enteroviruses which takes place in the natural host. Second, the differences observed may also be due to the type of T cell populations tested (polyclonal or clonal), nature of in vivo priming of the T cell populations studied in vitro (natural infection or immunization with non-replicating virus) or conditions of the in vitro stimulation tests. Third, other workers have used similar but not identical synthetic peptides to those studied in this work. Change in a single amino acid within a T cell epitope may affect the interaction with either the MHC molecule or the T cell receptor and lead to abolishment of the T cell activation (Burr et al., 1989) . Alternatively, although the peptides have the same critical amino acids, length of the peptide chain may affect T cell recognition via their effects on antigen processing (Reece et al., 1994) .
On the other hand, the sequences of the peptides selected in this study varied in some residues compared with the different enterovirus sequences reported. As has been mentioned above, a change in a single amino acid can dramatically alter the reactivity of a peptide. Therefore, we cannot rule out the possibility of having chosen some poorly reactive or non-reactive peptides. A set of analogous peptides, iiiiiiiiiiiiiiiiiiiii ii iii i ili iiiii i iiiiiiiiiiViiiiiiiiiiiiiiiiiiiiiiiiiiiiiii Fig. 3 . Effect of MHC class II blocking antibodies on IFN-7 production and proliferation in response to the different antigens. PBMC from donors F, H and J were incubated with a pool of MAbs to DR, DP and DQ molecules or with medium (no Ab, no antibodies). At the same time, peptides and CB5 virus were added to the PBMC of the different donors. (a) Proliferation was measured in donor F in response to E14 peptide and CB5 virus. (b) IFN-7 production was measured in donor D, H, and J in response to E13 peptide, E10 peptide, and E12 peptide respectively. (c) IFN-7 production was measured in donor D, H and J in response to CB5 virus. The peptides and CB5 virus were tested at concentrations of 25 I~g/ml and 12.5 pg/ml, respectively.
in which the variable residue is replaced by the alternative amino acid(s) could be synthesized in order to find other possible reactive peptides.
It is clearly shown in this study that some of the T cell epitopes would not have been identified if IFN-7 release had not been used as a measure of specific lymphocyte activation. This observation underlines the importance of examining several parameters of T cell activation when T cell epitope mapping is performed.
In keeping with findings from other laboratories, a poor correlation between the degree of antigen-specific T ceII proliferation and IFN-y production could be seen in this study (Hecht et a]., 1983; Troye-Blomberg eta]., 1990; Surcel et aL, 1994) . The lack of correlation between the two measurements was evident within each individual after peptide activation. These findings suggest that proliferating and IFN-?-producing T cells may belong to functionally different subsets. Alternatively, they may belong to the same subset but have distinct mechanisms regulating T cell proliferation and cytokine production.
Low proliferative capacity along with relatively high production of IFN-y upon antigen stimulation suggests that the response recorded was mainly mediated by memory T cells (Sanders et al., 1988) . Consistent with this interpretation is the fact that lymphocytes from human cord blood were not capable of responding to enteroviral antigens by production of IFN-y and proliferation. It has been suggested that memory T cells are stimulated and maintained via contact with crossreactive epitopes (Beverley, 1990) . If so, it is tempting to speculate that due to several enterovirus infections experienced during life, a pool of virus-specific memory T cells is maintained by repeated stimulations with enterovirus cross-reactive epitopes. Hence, it may well be that these memory T cells are highly differentiated with low or no capacity for proliferation and enhanced capacity for IFN-7 production. If this assumption proves to be correct it gives an alternative explanation to our results showing no proliferation but IFN-~ release from PBMC in response to synthetic peptides representing conserved sequences among enteroviruses.
The T cell responses observed in our study were mediated by CD4 + T cells in association with MHC class I! molecules. Humoral immunity appears to be of primary importance in the protection against enterovirus infections (Melnick, 1950) . Therefore, a predominance of Th2 cells which are best adapted to helping B cells produce antibody might be expected in enterovirus infections. However, our findings suggest that the human in vitro T cell response to enteroviruses is predominantly of a Thl type. This result is consistent with a recent report in which transgenic mice expressing the human poliovirus receptor have been used to study the immune response after exposure to poliovirus (Mahon et aL, I995) . These workers have shown that poliovirus-specific CD4 + Thl cells with both cytotoxic and helper activity mediate protective humoral immunity against poliovirus infection. The existence of CD4 + T lymphocytes with cytotoxic activity has also been described for a number of host-virus systems (Littaua et al., I992; Richt & Stitz, 1992; Zivny et aL, 1993) . Thus, our initial results in humans merit further investigation in order to characterize whether enterovirus-specific CD4 + ThI cells have cytotoxic and/or helper activity. We cannot rule out that the predominance of the Thl subset reported here was preferentially selected by the in vitro culture conditions as has been previously suggested (Littaua et aI., 1992) . Alternatively, one could speculate that in our system the amounts of IL-4 and IL-10 produced may have been sufficient to exert physiological effects but the concentrations may have been below the detection levels of our ELISA tests. It has been shown that in human PBMC, 20-40% of the lymphocytes produced IFN-7 and only 1-3 % of the lymphocytes synthesized IL-4 (Andersson et at., 1990) . These findings are in agreement with the results obtained in our study where mitogen-stimulated PBMC produced much higher levels of IFN-y ( > 7 ng/ml) than IL-4 and IL-10 (0"035--0"5 ng/ml).
Our results indicate that CD4 +, CD8 + and NK cells were the cellular sources of IFN-y released in response to antigen stimulation of PBMC. Although few patients were studied, it seems that there is a remarkable individual variation in the capacity of different cell subsets to produce IFN-y upon antigen stimulation. Also, IFN-y release by PBMC in response to individual peptides showed great variation among donors.
The finding of varying patterns of peptide-specific IFN-y production in this heterogeneous donor population is consistent with the ability of different MHC class II molecules in presenting peptides to CD4 + T helper cells. This variation seems also to be dependent on the individual capacity of CD8 + and NK cells to generate IFN-y in response to helper factors produced by CD4 + T cells. One question still to be addressed is how in this in vitro model CD8 + T ceils are induced to release IFN-y in response to a synthetic peptide (i.e. E12 peptide, donor J). One possibility is that CD4 + T cells are stimulated by the peptide to release cytokines which in a bystander fashion induce CD8 + T cells to produce IFN-7. Alternatively, or in addition, the peptide could bind to MHC class II as well as class I molecules and stimulate CD4 + cells and preactivate CD8 + ceils, respectively. The latter hypothesis is supported by several reports that have shown that peptides can bind to both class I and class II molecules (Perkins et al., 1989; Hickling et al., 1990; Takeshita eta] ., 1995).
In conclusion, this study has enabled us to identify novel human cross-reactive T cell epitopes localized in the structural proteins of enteroviruses. We have also shown the importance of measuring not only proliferation but also cytokine production when screening donor populations for T cell responsiveness to a given antigen. Furthermore, preliminary information is also provided for the involvement of Thl cells in the human cellular immune response in enterovirus infections. Our future aim is the establishment of T clones specific for the cross-reactive T cell epitopes described here. This may help to characterize in detail the fine specificity and function of T cells involved in the enterovirus cross-reactive T cell response.
